Age
Visit vs Plasminogen activation inhibitor-1 levels - AM reading
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 5 | 722 | 36.4 | ± 33.8 | 25.4 | 0.9 | 286.1 | 13 | 735 |
Participant's age (category) vs Plasminogen activation inhibitor-1 levels - AM reading
Visit 5
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 646 | 36.2 | ± 33.8 | 25.4 | 0.9 | 286.1 | 12 | 658 |
| 5-14 yrs old | 61 | 24.8 | ± 25.8 | 14.0 | 1.8 | 138.5 | 3 | 64 |
| 15-24 yrs old | 108 | 24.8 | ± 28.7 | 13.8 | 0.9 | 152.2 | 4 | 112 |
| 25-34 yrs old | 62 | 37.8 | ± 29.6 | 32.2 | 1.7 | 116.0 | - | 62 |
| 35-44 years | 97 | 35.7 | ± 34.4 | 24.0 | 1.1 | 148.3 | 1 | 98 |
| 45-54 years | 146 | 47.6 | ± 38.0 | 38.0 | 2.4 | 286.1 | 2 | 148 |
| 55-64 years | 83 | 44.6 | ± 39.2 | 32.0 | 2.0 | 261.6 | 1 | 84 |
| 65-74 years | 56 | 36.6 | ± 27.9 | 33.2 | 2.4 | 119.5 | 1 | 57 |
| 75-84 years | 31 | 22.4 | ± 17.5 | 16.2 | 4.8 | 69.9 | - | 31 |
| 85 years or older | 2 | 7.2 | ± 4.6 | 7.2 | 3.9 | 10.5 | - | 2 |
Participant's sex vs Plasminogen activation inhibitor-1 levels - AM reading
Visit 5
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 722 | 36.4 | ± 33.8 | 25.4 | 0.9 | 286.1 | 13 | 735 |
| Female | 398 | 33.8 | ± 32.1 | 24.8 | 1.1 | 286.1 | 8 | 406 |
| Male | 324 | 39.6 | ± 35.5 | 26.3 | 0.9 | 201.8 | 5 | 329 |
Participant's race vs Plasminogen activation inhibitor-1 levels - AM reading
Visit 5
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 722 | 36.4 | ± 33.8 | 25.4 | 0.9 | 286.1 | 13 | 735 |
| White | 299 | 38.3 | ± 36.7 | 26.2 | 1.1 | 286.1 | 5 | 304 |
| Black | 401 | 35.4 | ± 31.4 | 25.7 | 0.9 | 201.8 | 8 | 409 |
| More than one race | 22 | 29.1 | ± 35.5 | 13.1 | 2.6 | 121.7 | - | 22 |